For example, it was shown that PDLIM4 expression is downregulated in OV; that its expression is negatively correlated with clinical stage, lymphatic metastasis, and patient survival; and that the overexpression of PDLIM4 inhibits OV cell proliferation, migration, invasion, and xenograft tumor growth by suppressing STAT3 signaling activation [122]. Here, PDLIM4 is linked to neoplasm.